Laurus Labs Ltd reported exceptionally strong Q2 FY26 results

reported exceptionally strong Q2 FY26 results, with consolidated net profit surging 883% year-on-year to ₹195 crore from ₹20 crore in Q2 FY25. Revenue from operations rose 35.1% to ₹1,653 crore, and EBITDA increased 126% to ₹403 crore, with margins expanding to 24.4% from 14.6% earlier. The company’s CDMO (Contract Development and Manufacturing Organization) segment grew 53% to ₹518 crore, driving much of the profitability. EBITDA margins have expanded due to a favorable shift in product mix and improved operating leverage.